---
title: "OncoMed Pharmaceuticals, Inc. (OMED.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/OMED.US.md"
symbol: "OMED.US"
name: "OncoMed Pharmaceuticals, Inc."
---

# OncoMed Pharmaceuticals, Inc. (OMED.US)

## Company Profile

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cells”. They are leveraging their understanding of these tumor initiati...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/OMED.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/OMED.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/OMED.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.